Importance of IL-1beta in SARS-CoV-2 infection
International Journal of Pediatrics
; 10(9):16745-16757, 2022.
Article
in English
| CAB Abstracts | ID: covidwho-2251654
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provokes the host immune responses and induces severe respiratory syndrome by overreaction of immune cells. IL-1beta is a pro-inflammatory cytokine highly associated with the related inflammation and cytokine storm, and several IL-1beta antagonists are being used to treat cytokine release syndrome (CRS). Accordingly, some studies and clinical trials are investigating the effects of IL-1beta antagonists for controlling Coronavirus disease 2019 (COVID-19) associated CRS. Here, we will review any interaction and association between IL-1beta and SARS-CoV-2 infection.
Human Immunology and Allergology [VV055], Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210], Pharmacology [VV730], antagonists, coronavirus disease 2019, cytokines, drug therapy, drugs, human diseases, interleukin 1, medical treatment, viral diseases, man, Severe acute respiratory syndrome coronavirus 2, Homo, Hominidae, primates, mammals, vertebrates, Chordata, animals, eukaryotes, Severe acute respiratory syndrome-related coronavirus, Betacoronavirus, Coronavirinae, Coronaviridae, Nidovirales, positive-sense ssRNA Viruses, ssRNA Viruses, RNA Viruses, viruses, chemotherapy, medicines, pharmaceuticals, SARS-CoV-2, viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
English
Journal:
International Journal of Pediatrics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS